Woulgan Bioactive Beta-Glucan Gel is documented through several published papers and case studies
Woulgan contains SBG as an ancillary medicinal ingredient. In addition to having typical gel qualities aiding in optimal moist conditions and autolytic debridement etc, the SBG ingredient increases angiogenesis, cell proliferation and wound contraction. The positive effects of SBG in treatment of diabetic foot ulcers have been studied and showed a statistically significant positive effect of SBG in complete wound healing at week 8 compared to control.
You can access the above mentioned study, other publisher papers and our case studies on Woulgan from menu to the left.